FAM162A

Across TCGA pan-cancer cohorts, FAM162A RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of FAM162A’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where FAM162A RNA is repressed in tumor relative to normal tissue. In most cancer types FAM162A is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD, LUAD, and BRCA are the cancer types where FAM162A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM162A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	IV	−1.415	<.001	12	view →
LUAD	Male	All	+0.563	<.001	9	view →
BRCA	All	III,IV	+0.831	<.001	8	view →
LUSC	Female	All	+1.682	<.001	7	view →
UCEC	All	All	+0.547	<.001	6	view →
READ	All	All	−1.196	<.001	5	view →
STAD	All	All	−0.446	.005	4	view →
KIRC	Female	All	+0.427	.003	4	view →
LIHC	All	All	+0.273	.007	4	view →
HNSC	Male	IV	+0.850	.011	2	view →
PAAD	All	All	+0.790	.043	2	view →
CHOL	All	All	−0.467	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

FAM162A–COAD

Open the COAD breakdown →